The Christie NHS Foundation Trust
The Christie NHS Foundation Trust operates Europe's largest single-site cancer centre in Manchester, delivering radiotherapy, chemotherapy, proton beam therapy, and surgery through 15+ sites across Greater Manchester and Cheshire, serving NHS patients plus private and international partners.
- Company typePrivate
- Founded1892
- HeadquartersManchester, United Kingdom
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What The Christie NHS Foundation Trust does
The Christie NHS Foundation Trust is an NHS public benefit corporation operating Europe's largest single-site cancer centre from its Withington, Manchester headquarters, with a hub-and-spoke network of 15+ satellite treatment centres across Greater Manchester, Cheshire, Derbyshire, and North Staffordshire. Founded as a hospital in 1892 and established as a Foundation Trust in 2003, it employs between 1,001 and 5,000 staff and is the first UK hospital accredited as a comprehensive cancer centre and the first specialist hospital rated Outstanding twice by the CQC. Its core clinical offering covers radiotherapy (including MR-Linac, stereotactic, IMRT, VMAT), systemic anti-cancer therapy (chemotherapy, immunotherapy, CAR-T), proton beam therapy (the only UK high-energy proton beam facility), and specialized surgical oncology, supported by departments for colorectal and peritoneal oncology, neuro-oncology, lymphoma, and haematology.
Revenue is generated primarily through NHS England commissioning contracts for publicly funded cancer care, supplemented by private patient services delivered through an HCA Healthcare partnership, research funding from Cancer Research UK (currently over £17m/year to the co-located Manchester Institute), and charitable income via The Christie Charity subsidiary. The trust also pursues international advisory work through partnerships in Egypt, Kenya, Kazakhstan, Malta, Jordan, Australia, and Ireland, and has invested in digital transformation (Netcall Liberty Spark) that has retired 30% of forms and reduced manual data entry by up to 50% across 70+ mapped care processes. Patient-facing channels include the MyChristie portal, Attend Anywhere video clinics, The Christie at Home service, and a Bloods Closer to Home phlebotomy network.
The Christie NHS Foundation Trust firmographics
Firmographics- Name
- The Christie NHS Foundation Trust
- Legal name
- The Christie NHS Foundation Trust
- Website
- https://christie.nhs.uk
- Company type
- Private
- Founded year
- 1892
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- The Christie NHS Foundation Trust operates Europe's largest single-site cancer centre in Manchester, delivering radiotherapy, chemotherapy, proton beam therapy, and surgery through 15+ sites across Greater Manchester and Cheshire, serving NHS patients plus private and international partners.
- Ownership category
- akta.pro rank
The Christie NHS Foundation Trust industry classification
Industry- Product category
- Specialty Cancer Hospital Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Offices of Physicians (62111)
- SIC
- Services-Hospitals (8060), Services-Health Services (8000)
- akta.pro primary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
- akta.pro secondary industries
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Radiation Oncology (HLAKAFAC), Medical Oncology (HLAKAFAB)
Keywords
Where The Christie NHS Foundation Trust is headquartered
LocationHeadquarters
- HQ city
- Manchester
- HQ country
- United Kingdom
- HQ region
- Europe
Offices12 records
Markets served
The Christie NHS Foundation Trust business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Others
Revenue model
- NHS Publicly Funded Healthcare: The Christie operates as an NHS Foundation Trust, providing publicly funded cancer care services commissioned by NHS England and local clinical commissioning groups. Revenue is derived from NHS service contracts based on activity and population needs.
- Private Patient Services: The trust offers private care options through a partnership with HCA Healthcare, providing self-pay and insured patients with access to Christie specialists outside NHS pathways.
- Research Funding and Clinical Trials: The trust receives research funding from Cancer Research UK and other grant bodies. Additional funding of £6m per year increase announced for Manchester Institute, with two clinician scientist positions in partnership with The Christie.
Go-to-market motion1 record
Distribution channels7 records
Marketing channels6 records
The Christie NHS Foundation Trust product offering
Product offeringCore offering
The Christie NHS Foundation Trust is a specialist comprehensive cancer centre that diagnoses and treats cancer through radiotherapy (including MR-Linac, stereotactic, IMRT, VMAT), systemic anti-cancer therapy (chemotherapy, immunotherapy), proton beam therapy, surgery (including CAR-T cell therapy and brachytherapy), and supportive care. Services are delivered at the main Withington site in Manchester and through a network of 15+ satellite treatment centres across Greater Manchester and Cheshire. The Trust also runs clinical trials, research programmes in partnership with Cancer Research UK, and offers private patient services through HCA Healthcare.
Product overview
The Christie NHS Foundation Trust is a specialized cancer hospital providing integrated cancer care services. The Trust operates as a single unified hospital with distributed satellite sites, offering a comprehensive portfolio of treatment services including radiotherapy, systemic anti-cancer therapy (SACT), proton beam therapy, surgery, CAR-T cell therapy, and brachytherapy. These core clinical services are supported by specialized departments including the Colorectal and Peritoneal Oncology Centre, Neuro-oncology, Lymphoma, and Haematology. Patient-facing digital services include the MyChristie patient portal with health monitoring capabilities, The Christie at Home for remote treatment delivery, and the Bloods Closer to Home phlebotomy service. The Trust maintains additional support services through Christie Medical Physics and Engineering and The Christie Pharmacy.
Differentiator
Problem solved
Functional benefit
Brands
- MyChristie: Patient portal allowing patients to access appointments, test results, and manage their care.
- The Christie Charity
Products and services
- Radiotherapy
- Systemic Anti-Cancer Therapy (SACT)
- Proton Beam Therapy
- Surgery
- CAR-T Cell Therapy
- Brachytherapy
- Colorectal and Peritoneal Oncology Centre (CPOC)
- Neuro-oncology Service
- Lymphoma Service
- Haematology and Transplant Unit
- MyChristie Patient Portal
- The Christie at Home
- Bloods Closer to Home
- The Christie at Macclesfield
Quantifiable outcome
- 46,000 patient appointments and visits per year at Macclesfield site alone
- +4 more outcomes
Companies that use The Christie NHS Foundation Trust
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles5 records
The Christie NHS Foundation Trust technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature2 records
The Christie NHS Foundation Trust partnerships and signals
Strategic signalPartnerships
17 partnerships are on record, tiered core and minor.
- Cancer Research UK Manchester InstitutecoreCancer Research UK announced increased annual investment from £11m to more than £17m, representing £6m additional per year. The funding supports recruitment of up to eight senior researchers and up to 100 new research positions focused on immunology, data science, and AI. Two new clinician scientist positions established in partnership with The Christie hospital, with directly connected facilities enabling rapid transfer of patient samples to research labs.
- Poolbeg PharmaminorPoolbeg Pharma announced that its POLB 001 TOPICAL trial will be part of the RISE research programme focused on reducing cytokine release syndrome in cancer immunotherapy. Johnson & Johnson is providing a bispecific antibody for the programme.
- Johnson & JohnsonminorJohnson & Johnson is providing a bispecific antibody for the RISE research programme focused on reducing cytokine release syndrome in cancer immunotherapy. The programme aims to improve safety of advanced cancer therapies.
- NetcallcoreThe Christie completed a four-month digital transformation project using Netcall's Liberty Spark to map and analyze over 70 care processes across nine patient pathways. The initiative achieved efficiency gains and is being considered as a model for other NHS trusts.
- HCA HealthcarecorePartnership for private care services. HCA Healthcare operates The Christie Private Care facility, providing self-pay and insured patients access to Christie cancer specialists in private healthcare settings.
- Health Innovation ManchestercorePartnership focused on health innovation initiatives in the Greater Manchester region, supporting innovation and improvement in cancer care delivery.
- Manchester Cancer Research Centre (MCRC)corePartnership with Manchester Cancer Research Centre for collaborative cancer research activities, combining clinical expertise with research capabilities.
- Greater Manchester Cancer VanguardminorCollaboration through the Greater Manchester Cancer Vanguard initiative to advance cancer care across the region.
- Cork University HospitalminorInternational partnership supporting cancer care development at Cork University Hospital.
- King Hussein Cancer Centre (Jordan)minorPartnership with Colorectal and Peritoneal Oncology Centre (CPOC) and The King Hussein Cancer Centre for international collaboration in cancer care.
- Peter MacCallum Cancer Centre (Australia)minorInternational collaboration with The Peter MacCallum Cancer Centre in Australia to strengthen cancer research and treatment capabilities.
- Egypt Healthcare AuthorityminorPartnership working with Egypt Healthcare Authority to improve cancer outcomes through Christie expertise and advisory services.
- African Medical Centre of ExcellenceminorSupporting the African Medical Centre of Excellence project to develop cancer care capabilities in Africa through Christie advisory and expertise.
- MATER DEI Hospital (Malta)minorProviding advisory services to MATER DEI Hospital in Malta for oncology service development.
- Kenyan Healthcare PartnersminorWorking with Kenyan partners to improve cancer outcomes through training, advisory, and support services.
- Kazakhstan Medical Training PartnersminorChristie helps train doctors in Kazakhstan to improve cancer care capabilities in the region.
- King's International ConsortiumminorMember of King's International Consortium for global health collaboration and cancer care improvement.
Scale indicators10 records
Recent moves7 records
Expansion highlights6 records
The Christie NHS Foundation Trust competitors and assessment
Company assessmentDirect peers
- The Royal Marsden NHS Foundation Trust: UK's other flagship specialist cancer hospital, also NHS Foundation Trust, providing comprehensive oncology services including radiotherapy, SACT, surgery, and clinical trials; the closest direct comparator to The Christie in scale, scope, and academic standing.
- The Clatterbridge Cancer Centre NHS Foundation Trust: Specialist NHS cancer centre covering Merseyside and Cheshire with multiple radiotherapy and chemotherapy sites; directly comparable operating model and satellite network structure to The Christie.
Broad incumbents
- University College London Hospitals NHS Foundation Trust: Major London academic NHS trust running a substantial haemato-oncology and cancer service alongside general acute specialties; overlapping tertiary cancer referrals and research partnerships.
- Guy's and St Thomas' NHS Foundation Trust: Large London NHS Foundation Trust with comprehensive cancer services including radiotherapy, SACT and clinical trials; comparable NHS academic hospital structure with research leadership.
- MD Anderson Cancer Center: World-leading US comprehensive cancer centre operating at far larger scale; benchmarks research intensity, proton beam therapy and CAR-T capability that The Christie aspires to scale.
- Memorial Sloan Kettering Cancer Center: US comprehensive cancer centre with deep research portfolio and clinical trial leadership; comparable in offering the full cancer care continuum from a single specialist footprint.
- Imperial College Healthcare NHS Trust: London-based academic NHS trust with significant oncology services and translational research; comparable NHS academic provider model though not exclusively cancer-focused.
Emerging players
- GenesisCare: Private specialist provider of radiotherapy and oncology services across the UK and Australia; competes for private and insured patients and overlaps with The Christie's private offering.
Others
- HCA Healthcare UK: Christie's private care partner delivering self-pay and insured oncology services at The Christie Private Care; relevant as both distribution partner and indirect private competitor.
Regional players
- Peter MacCallum Cancer Centre: Australia's only public specialist cancer hospital, with similar comprehensive cancer centre model and active research partnership with The Christie; comparable peer despite operating in a different geography.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
The Christie NHS Foundation Trust social profiles
Digital presenceThe Christie NHS Foundation Trust compliance and trust
Trust signalCompliance2 records
The Christie NHS Foundation Trust financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Christie NHS Foundation Trust leadership team
Management profileNumber of profiles
Profiles1 record
The Christie NHS Foundation Trust subsidiaries and ownership
Company hierarchySubsidiaries3 records
The Christie NHS Foundation Trust funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Christie NHS Foundation Trust M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Christie NHS Foundation Trust
What does The Christie NHS Foundation Trust do?
The Christie NHS Foundation Trust is a specialist comprehensive cancer centre that diagnoses and treats cancer through radiotherapy (including MR-Linac, stereotactic, IMRT, VMAT), systemic anti-cancer therapy (chemotherapy, immunotherapy), proton beam therapy, surgery (including CAR-T cell therapy and brachytherapy), and supportive care. Services are delivered at the main Withington site in Manchester and through a network of 15+ satellite treatment centres across Greater Manchester and Cheshire. The Trust also runs clinical trials, research programmes in partnership with Cancer Research UK, and offers private patient services through HCA Healthcare.
Is The Christie NHS Foundation Trust a public or private company?
The Christie NHS Foundation Trust is a private company. It is classified as state government owned and is currently operating.
When was The Christie NHS Foundation Trust founded?
The Christie NHS Foundation Trust was founded in 1892. It employs 1,001 to 5,000 people.
Where is The Christie NHS Foundation Trust based?
The Christie NHS Foundation Trust is headquartered in Manchester, United Kingdom, in the Europe region.
How does The Christie NHS Foundation Trust make money?
Three revenue lines are on record. NHS Publicly Funded Healthcare is the primary driver. The others are private Patient Services and research Funding and Clinical Trials.
Who are The Christie NHS Foundation Trust's main competitors?
Direct peers on record are The Royal Marsden NHS Foundation Trust and The Clatterbridge Cancer Centre NHS Foundation Trust. Broad incumbents are University College London Hospitals NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center and Imperial College Healthcare NHS Trust. GenesisCare is listed as an emerging player. HCA Healthcare UK is listed as an others. Peter MacCallum Cancer Centre is listed as a regional player.
Does The Christie NHS Foundation Trust have an API?
No public API is recorded for The Christie NHS Foundation Trust.
What industry is The Christie NHS Foundation Trust in?
The Christie NHS Foundation Trust's product category is Specialty Cancer Hospital Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 622310 and its SIC code is 8060.